These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35432786)

  • 1. Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.
    Ridgway H; Moore GJ; Mavromoustakos T; Tsiodras S; Ligielli I; Kelaidonis K; Chasapis CT; Gadanec LK; Zulli A; Apostolopoulos V; Petty R; Karakasiliotis I; Gorgoulis VG; Matsoukas JM
    Comput Struct Biotechnol J; 2022; 20():2091-2111. PubMed ID: 35432786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics.
    Kelaidonis K; Ligielli I; Letsios S; Vidali VP; Mavromoustakos T; Vassilaki N; Moore GJ; Hoffmann W; Węgrzyn K; Ridgway H; Chasapis CT; Matsoukas JM
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
    Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
    Viruses; 2022 May; 14(5):. PubMed ID: 35632769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.
    Moore GJ; Ridgway H; Kelaidonis K; Chasapis CT; Ligielli I; Mavromoustakos T; Bojarska J; Matsoukas JM
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.
    Agelis G; Resvani A; Koukoulitsa C; Tůmová T; Slaninová J; Kalavrizioti D; Spyridaki K; Afantitis A; Melagraki G; Siafaka A; Gkini E; Megariotis G; Grdadolnik SG; Papadopoulos MG; Vlahakos D; Maragoudakis M; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2013 Apr; 62():352-70. PubMed ID: 23376252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.
    Ridgway H; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Hoffmann W; Węgrzyn K; Vassilaki N; Mpekoulis G; Zouridakis M; Giastas P; Vidali VP; Kelaidonis K; Matsoukas MT; Dimitriou M; Mavromoustakos T; Tsiodras S; Gorgoulis VG; Karakasiliotis I; Chasapis CT; Matsoukas JM
    Expert Opin Ther Targets; 2024 May; 28(5):437-459. PubMed ID: 38828744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.
    Gadanec LK; Swiderski J; Apostolopoulos V; Kelaidonis K; Vidali VP; Canko A; Moore GJ; Matsoukas JM; Zulli A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019.
    Apostolopoulos V; Georgiou N; Tzeli D; Mavromoustakos T; Moore GJ; Kelaidonis K; Matsoukas MT; Tsiodras S; Swiderski J; Kate Gadanec L; Zulli A; Chasapis CT; Matsoukas JM
    Bioorg Chem; 2024 Jun; 150():107602. PubMed ID: 38959647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
    Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
    Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
    Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
    Eur J Pharmacol; 1996 Jul; 307(3):259-67. PubMed ID: 8836613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Matsoukas JM; Gadanec LK; Zulli A; Apostolopoulos V; Kelaidonis K; Ligielli I; Moschovou K; Georgiou N; Plotas P; Chasapis CT; Moore G; Ridgway H; Mavromoustakos T
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19.
    Moore GJ; Pires JM; Kelaidonis K; Gadanec LK; Zulli A; Apostolopoulos V; Matsoukas JM
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
    Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
    Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.